Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients

In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personalized therapy and to predict treatment response. We conducted a prospective study to evaluate the usefulness of circulating exosomal-PD-L1 in melanoma patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordonnier, Marine, Nardin, Charlée, Chanteloup, Gaëtan, Derangere, Valentin, Algros, Marie-Paule, Arnould, Laurent, Garrido, Carmen, Aubin, François, Gobbo, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968537/
https://www.ncbi.nlm.nih.gov/pubmed/32002173
http://dx.doi.org/10.1080/20013078.2019.1710899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968537/
https://www.ncbi.nlm.nih.gov/pubmed/32002173
http://dx.doi.org/10.1080/20013078.2019.1710899

Ejemplares similares